Idex (IEX) FY2025 results: revenue $3.5 billion, up 5.8% on the year
Idex Corp. (IEX) reported revenue of $3.5 billion for fiscal 2025, the year ended 31 December 2025, up 5.8% on the year before. Net income was $483 million, down 4.3%, and diluted earnings per share $6.41. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2026.
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 4 new.
- Record fourth-quarter sales; modest organic growth: Reported growth came from acquisitions, organic sales and favorable currency; organic growth came from positive price, partly offset by lower FSDP and FMT volumes.
- Fourth-quarter EPS rose on operations: Reported diluted EPS of $1.71 rose 6% and adjusted diluted EPS of $2.10 rose 3%. Management attributed both increases largely to improved operational results.
- Record orders concentrated in HST: Orders were a record for the quarter, and management attributed most of the increase to HST, where order growth built during the quarter.
- HST orders tied to AI projects: Management linked the fourth-quarter HST order build to increasing demand for AI-related projects, including data center power and semiconductor applications.
- FMT and FSDP managing challenging demand: Management described demand in the FMT and FSDP segments as challenging, with those businesses managing the factors within their control.
From this 10-K
IDEX is an applied solutions provider serving niche markets with components used in everyday life. Almost all of the business runs through over 50 wholly-owned subsidiaries that operate with a high degree of autonomy under a shared operating philosophy the company calls The IDEX Difference, built on the 8020 principle. It was incorporated in Delaware on 24 September 1987. There are three reportable segments, Health and Science Technologies, Fluid and Metering Technologies, and Fire and Safety/Diversified Products, each grouping businesses with similar products, end markets, distribution and production processes. In 2025 those segments were 43%, 35% and 22% of segment sales.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 3,458 | 3,269 | 3,274 | +5.8% | |
| Cost of revenue | 1,919 | 1,824 | 1,827 | +5.2% | |
| Gross profit | 1,539 | 1,445 | 1,447 | +6.5% | |
| Gross margin | 44.5% | 44.2% | 44.2% | ||
| Research and development | 70.0 | 67.4 | 68.4 | +3.9% | |
| Selling, general and administrative | 819 | 759 | 704 | +7.9% | |
| Operating income | 699 | 677 | 732 | +3.3% | |
| Operating margin | 20.2% | 20.7% | 22.4% | ||
| Interest expense | 64.4 | 44.5 | 51.7 | +44.7% | |
| Pre-tax income | 633 | 639 | 760 | -1.0% | |
| Income tax | 150 | 135 | 165 | +11.4% | |
| Effective tax rate | 23.7% | 21.1% | 21.7% | ||
| Net income | 483 | 505 | 596 | -4.3% | |
| Net margin | 14.0% | 15.4% | 18.2% | ||
| Diluted EPS | $6.41 | $6.64 | $7.85 | -3.5% |
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | 680 | 668 | 717 | +1.8% | |
| Capital expenditure | 63.6 | 65.1 | 89.9 | -2.3% | |
| Free cash flow | 617 | 603 | 627 | +2.3% | |
| Free cash flow margin | 17.8% | 18.4% | 19.1% | ||
| Cash from investing | -138 | -1,006 | -284 | ||
| Cash from financing | -633 | 466 | -345 | ||
| Depreciation and amortisation | 206 | 176 | 152 | +17.6% | |
| Share-based compensation | 27.3 | 25.8 | 21.8 | +5.8% | |
| Buybacks | 248 | 0.0 | 24.2 | ||
| Dividends paid | 213 | 205 | 191 | +3.6% | |
| Dividend per share | $2.84 | $2.76 | $2.56 | +2.9% | |
| Diluted shares, weighted | 75m | 76m | 76m | -0.8% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | 4,028 | 3,795 | 3,541 | +6.1% | |
| Non-controlling interest | -1.3 | -0.6 | -0.2 | ||
| Debt | 1,830 | 1,971 | 1,333 | -7.2% | |
| Operating lease liabilities | 94.1 | 102 | 98.1 | -7.4% | |
| Other liabilities | 977 | 878 | 893 | +11.2% | |
| Total liabilities and equity | 6,927 | 6,745 | 5,865 | +2.7% | |
| Fixed assets | 468 | 460 | 430 | +1.7% | |
| Goodwill | 3,414 | 3,252 | 2,838 | +5.0% | |
| Intangible assets | 1,247 | 1,285 | 1,012 | -2.9% | |
| Cash and equivalents | 580 | 621 | 534 | -6.6% | |
| Receivables | 512 | 461 | 419 | +11.0% | |
| Inventory | 479 | 430 | 421 | +11.6% | |
| Other assets | 226 | 237 | 211 | -4.7% | |
| Total assets | 6,927 | 6,745 | 5,865 | +2.7% |
10-K for the year ended 31 December 2025, filed 19 February 2026: the filing.